B. U. Shanthappa

Most-cited papers

1. Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity

   B. Majumder, U. Baraneedharan, S. Thiyagarajan, P. Radhakrishnan +19 more

   2015Nature Communications290 citations Open access

   Semantic Scholar

   Save

2. Nano-Engineered Disruption of Heat shock protein 90 (Hsp90) Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer

   Munisha Smalley, Sivaraman Natarajan, Jayanta Mondal, Douglas Best +16 more

   2020Cancer Research12 citations Open access

   Semantic Scholar

   Save

3. Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions

   S. Darabi, A. Elliott, David R. Braxton, Jia Zeng +13 more

   2022Cancers8 citations Open access

   Semantic Scholar

   Save

4. Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response Dynamics

   Munisha Smalley, M. Przedborski, S. Thiyagarajan, M. Pellowe +14 more

   2020iScience8 citations Open access

   Semantic Scholar

   Save

5. Duvelisib with Docetaxel for Patients with Anti–PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma

   Glenn J. Hanna, L. B. Oakley, R. Shi, A. ONeill +17 more

   2024Clinical Cancer Research4 citations Open access

   Semantic Scholar

   Save

6. Predicting tumor-immune response to checkpoint inhibitors using a novel patient-derived live tumor explant model.

   P. Radhakrishnan, Aaron Goldman, Baraneedharan Ulaganathan, Allen Thaya Kumar +7 more

   20172 citations

   Semantic Scholar

   Save

7. Abstract P6-07-03: A live tissue platform allows dynamic measurement of neovascularization and prediction of clinical response in human breast cancer samples,ex vivo

   Munisha Smalley, N. Alam, N. Murmu, S. Somashekhar +8 more

   2019Poster Session Abstracts0 citations

   Semantic Scholar

   Save

8. Abstract LB-346: Case study: Non-uniform response to therapy in multiple metastatic is predicted using CANscriptTM, a live tissue,ex-vivo, platform

   C. Ikpeazu, Munisha Smalley, Baraneedharan Ulaganathan, Allen Thayakumar +7 more

   2018Tumor Biology0 citations

   Semantic Scholar

   Save

9. Abstract 4064: Spatial re-distribution of natural killer cells targets drug resistance and anti-tumor response,ex-vivo

   Munisha Smalley, B. U. Shanthappa, H. Gertje, M. Lawson +9 more

   2018Tumor Biology0 citations

   Semantic Scholar

   Save

10. Predicting unreported clinical trial efficacy using an ex-vivo tumor platform: Pembrolizumab+pt+5-FU vs. extreme in recurrent head and neck squamous cell carcinoma.

    Munisha Smalley, S. Thiyagarajan, B. Majumder, N. Basak +12 more

    20180 citations

    Semantic Scholar

    Save

11. Abstract P5-11-04: Therapy-induced priming of natural killer cells predicts patient-specific tumor rejection in multiple breast cancer indications

    Munisha Smalley, B. U. Shanthappa, H. Gertje, M. Lawson +10 more

    20180 citations

    Semantic Scholar

    Save

12. Abstract 705: Nonuniform T-cell infiltration induced by PD-1 checkpoint blockade,ex vivo,predicts distinct clinical response

    Munisha Smalley, B. U. Shanthappa, H. Gertje, M. Lawson +8 more

    2018Immunology0 citations

    Semantic Scholar

    Save

13. 29PTherapy-induced priming of natural killer cells predicts patient-specific tumor rejection in multiple breast cancer indications

    Munisha Smalley, B. U. Shanthappa, H. Gertje, M. Lawson +10 more

    20170 citations Open access

    Semantic Scholar

    Save